These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 34599019)
1. Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors. Marcu A; Schlosser A; Keupp A; Trautwein N; Johann P; Wölfl M; Lager J; Monoranu CM; Walz JS; Henkel LM; Krauß J; Ebinger M; Schuhmann M; Thomale UW; Pietsch T; Klinker E; Schlegel PG; Oyen F; Reisner Y; Rammensee HG; Eyrich M J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599019 [TBL] [Abstract][Full Text] [Related]
2. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry. Freudenmann LK; Marcu A; Stevanović S Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117 [TBL] [Abstract][Full Text] [Related]
3. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related]
4. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry. Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844 [TBL] [Abstract][Full Text] [Related]
6. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. Marcu A; Bichmann L; Kuchenbecker L; Kowalewski DJ; Freudenmann LK; Backert L; Mühlenbruch L; Szolek A; Lübke M; Wagner P; Engler T; Matovina S; Wang J; Hauri-Hohl M; Martin R; Kapolou K; Walz JS; Velz J; Moch H; Regli L; Silginer M; Weller M; Löffler MW; Erhard F; Schlosser A; Kohlbacher O; Stevanović S; Rammensee HG; Neidert MC J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858848 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation. Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100 [TBL] [Abstract][Full Text] [Related]
8. The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Neidert MC; Kowalewski DJ; Silginer M; Kapolou K; Backert L; Freudenmann LK; Peper JK; Marcu A; Wang SS; Walz JS; Wolpert F; Rammensee HG; Henschler R; Lamszus K; Westphal M; Roth P; Regli L; Stevanović S; Weller M; Eisele G Acta Neuropathol; 2018 Jun; 135(6):923-938. PubMed ID: 29557506 [TBL] [Abstract][Full Text] [Related]
9. Immune cell infiltrates in atypical teratoid/rhabdoid tumors. Lu JQ; Wilson BA; Yong VW; Pugh J; Mehta V Can J Neurol Sci; 2012 Sep; 39(5):605-12. PubMed ID: 22931701 [TBL] [Abstract][Full Text] [Related]
10. Identification of the Cryptic HLA-I Immunopeptidome. Erhard F; Dölken L; Schilling B; Schlosser A Cancer Immunol Res; 2020 Aug; 8(8):1018-1026. PubMed ID: 32561536 [TBL] [Abstract][Full Text] [Related]
11. Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation. Löffler MW; Kowalewski DJ; Backert L; Bernhardt J; Adam P; Schuster H; Dengler F; Backes D; Kopp HG; Beckert S; Wagner S; Königsrainer I; Kohlbacher O; Kanz L; Königsrainer A; Rammensee HG; Stevanović S; Haen SP Cancer Res; 2018 Aug; 78(16):4627-4641. PubMed ID: 29789417 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
13. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22. Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605 [TBL] [Abstract][Full Text] [Related]
14. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy. Bilich T; Nelde A; Bichmann L; Roerden M; Salih HR; Kowalewski DJ; Schuster H; Tsou CC; Marcu A; Neidert MC; Lübke M; Rieth J; Schemionek M; Brümmendorf TH; Vucinic V; Niederwieser D; Bauer J; Märklin M; Peper JK; Klein R; Kohlbacher O; Kanz L; Rammensee HG; Stevanović S; Walz JS Blood; 2019 Feb; 133(6):550-565. PubMed ID: 30530751 [TBL] [Abstract][Full Text] [Related]
15. Atypical teratoid/rhabdoid tumors of the central nervous system. Reddy AT J Neurooncol; 2005 Dec; 75(3):309-13. PubMed ID: 16195799 [TBL] [Abstract][Full Text] [Related]
16. Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET. Garcia-Moure M; Gonzalez-Huarriz M; Labiano S; Guruceaga E; Bandres E; Zalacain M; Marrodan L; de Andrea C; Villalba M; Martinez-Velez N; Laspidea V; Puigdelloses M; Gallego Perez-Larraya J; Iñigo-Marco I; Stripecke R; Chan JA; Raabe EH; Kool M; Gomez-Manzano C; Fueyo J; Patiño-García A; Alonso MM Clin Cancer Res; 2021 Mar; 27(6):1807-1820. PubMed ID: 33376098 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel human leukocyte antigen-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. Ji J; Judkowski VA; Liu G; Wang H; Bunying A; Li Z; Xu M; Bender J; Pinilla C; Yu JS Stem Cells Transl Med; 2014 Mar; 3(3):356-64. PubMed ID: 24375541 [TBL] [Abstract][Full Text] [Related]
20. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation. Goncalves G; Mullan KA; Duscharla D; Ayala R; Croft NP; Faridi P; Purcell AW Front Immunol; 2021; 12():645770. PubMed ID: 33968037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]